In the title compound, C 25 H 20 O 3 , the central -C( O)-C C-chain is disordered over two positions about the central C atom, with an occupancy ratio of 0.848 (6):0.152 (6). The molecule is twisted with the two naphthalene ring systems being inclined to one another by 52.91 (9) . In the crystal, molecules are linked by C-HÁ Á Á interactions, forming a three-dimensional structure. The structure was refined as a two-component twin with a 180 rotation about the c* axis.
Related literature
For natural sources of chalcones and their derivatives, see: Anderson & Markham (2006) ; Yadav et al. (2011) . For examples of their biological activities, see: Liu et al. (2011) ; Siddiqui et al. (2012) . For their use as synthons for the preparation of five-and six-membered ring systems, see: Powers et al. (1998) . For their use as intermediates in the synthesis of pharmaceutical molecules, see: Perozo-Rondon et al. (2006) . For the crystal structure of a closely related compound, 3-(6-methoxy-2-naphthyl)-1-(2-naphthyl)prop-2-en-1-one, see: Yathirajan et al. (2006) . Table 1 Hydrogen-bond geometry (Å , ).
Cg2 and Cg4 are the centroids of rings C5-C10 and C17-C22, respectively. 
Data collection: APEX2 (Bruker, 2004 ); cell refinement: APEX2 and SAINT (Bruker, 2004) ; data reduction: SAINT and XPREP (Bruker, 2004 ); program(s) used to solve structure: SIR92 (Altomare et al., 1993); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015) ; molecular graphics: ORTEP-3 for Windows (Farrugia, 2012) and Mercury (Macrae et al., 2008) ; software used to prepare material for publication: SHELXL2014 and PLATON (Spek, 2009 ).
S1. Comments
Heteroaryl chalcones are well documented as important synthons for a number of pharmaceutically active molecules, and extensive investigations have demonstrated the biological properties of natural and synthetic chalcones. These properties are largely attributed to the presence of the a,ß-unsaturated ketone moiety in the chalcone (Anderson & Markham, 2006; Yadav et al., 2011) . Chalcones are reported to possess many useful properties, for example antibacterial [Liu et al., 2011] and antifungal [Siddiqui et al., 2012] . These compounds are important synthons for the preparation of five-and sixmembered ring systems [Powers et al., 1998 ] as well as intermediates in the synthesis of many pharmaceutically useful molecules [Perozo-Rondon et al., 2006] . Given such varied pharmacological activities and synthetic utilities, chalcones have always attracted chemists to develop newer molecules and study their biological activities. Adding to the list of active heteroaryl chalcones for use in pharmaceutical applications and as an effective synthon for the preparation of fiveand six-member ring systems, we report herein on the synthesis and crystal structure of the title compound.
In the title compound, Fig. 1 , the central -C12(═O2)-C13═C14-chain is disordered over two positions about the central atom C13 with an occupancy ratio of 0.848 (6):0.152 (6) for atom O2 (O2A:O2B). The molecule is twisted with the two naphthalene ring systems being inclined to one another by 52.91 (9)°. This situation is similar to that in compound 3-(6-methoxy-2-naphthyl)-1-(2-naphthyl)prop-2-en-1-one (Yathirajan et al., 2006) , where the two naphthalene ring systems are inclined to one another by 54.41 (3) °.
In the crystal, molecules are linked by C-H···π interactions forming a three-dimensional structure. There are no other intra-or inter-molecular interactions present.
S2. Synthesis and crystallization
To a stirred solution of 6-methoxy-2-naphthaldehyde (1.86 g, 10 mmol) in ethanol (10 ml), 1-(6-methoxynaphthalen-2-yl) ethanone (2.00 g, 10 mmol) dissolved in ethanol (10 ml) was added portion wise. The reaction mixture was stirred at room temperature for an additional 20 min, during which time it turned to a homogeneous solution. KOH solution (40%, 2 ml) was then added drop wise and the resultant mixture was stirred at room temperature for 2 h. The precipitated product was then collected by filtration and purified by recrystallization from chloroform-methanol (1:1 v/v, 10 ml), to afford 2.29 g (82%) of the title compound as yellow-brown needles (m.p.: 396-397 K). Colourless block-like crystals, suitable for X-ray diffraction, were obtained by crystallization from a 1 ml saturated solution in ethanol.
S3. Refinement
Crystal data, data collection and structure refinement details are summarized in Table 2 . The H atoms were included in calculated positions and treated as riding atoms: C-H = 0.93-0.96 Å with U iso (H) = 15.U eq (C-methyl) and 1.2U eq (C) for other H atoms. The central -C12(═O2)-C13═C14-chain is disordered over two positions about the central atom C13
with an occupancy ratio of 0.848 (6):0.152 (6) for atom O2 (O2A:O2B). The structure was refined as a two-component 
Figure 1
The molecular structure of the title compound, with atom labelling. Displacement ellipsoids are drawn at the 50% probability level. Only the major component of the disordered O atom is shown. 
